Trial intelligence / Profile preview

PREDICORT: Prednisone PK/PGx in Giant Cell Arteritis

NCT01400464Phase 4Unknown

Sponsor
CHU Caen Normandie
Start
Jul 2009
Primary completion
Sep 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of prednisone in giant cell arteritis (GCA), sponsored by CHU Caen Normandie. Status: unknown.

02

Drugs

prednisone
03

Conditions

giant cell arteritis (GCA)

Beyond the preview

Go deeper on NCT01400464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01400464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call